Skip to content
Monday, November 23, 2026
Military News

ARRW revived, production has begun but deployment is still pending

B-52 폭격기 외부 장착대에 탑재된 AGM-183A ARRW 극초음속 미사일

The ARRW program, which was nearly canceled, has returned to the production phase.

The U.S. Air Force has moved the AGM-183A ARRW, whose purchase it had announced would be halted in 2023, back into the production phase. The contract with Lockheed Martin is valued at $694 million. The contract was signed on September 29, 2026, and publicly announced on October 26, 2026.

However, the exact deployment date is still unknown.

The U.S. Air Force has not disclosed the production quantity under this contract or when the missiles will be delivered. Therefore, the fact that a production contract has been signed alone does not mean that the ARRW has been operationally deployed to U.S. military combat units. The contract has been confirmed, but the schedule for operational deployment remains undetermined.

Reasons for repeated production after failure.

ARRW is an air-to-ground weapon that accelerates with a rocket booster and then glides without propulsion using a boost-glide approach. GAO explains that hypersonic weapons generally fly at Mach 5 or faster and can maneuver in flight, making them difficult to detect, track, and intercept.

However, the development process of the ARRW was not smooth. According to the GAO, the first successful flight test of a fully functional prototype occurred in December 2022. Subsequently, in 2023, there were test failures related to defects in the missile cover and thermal shielding.

As testing problems continued, the U.S. Air Force announced in 2023 that it would discontinue purchasing ARRW and focus its resources on HACM. While ARRW uses a rocket booster and a glide vehicle, HACM is a scramjet-based air-breathing hypersonic cruise missile.

However, the project has been revived. The U.S. Air Force included funding for the ARRW (Air-Launched Rapid Response Weapon) in its FY2026 budget, and in the FY2027 budget, it separately planned for ARRW Increment 2. The procurement budget for ARRW in FY2027 was $452 million, while the budget for FY2026 was $362 million.

A project that was on the verge of being canceled has been revived.

Increment 2 includes a terminal seeker, data link, hardware improvements, and cost reduction efforts. The U.S. Air Force is developing a terminal seeker and data link functions that can target moving objects. However, it has not been confirmed to what extent these functions have actually been developed.

A production contract is not a production order.

The U.S. Air Force described this measure as a transition for the ARRW from the prototype development and flight testing phases to the production phase. Air Force Secretary Troy Meink stated, “This is a turning point in our advanced weapons roadmap.”

He stated that he would move ARRW into production to provide combatant commanders with high-speed strike weapons and enable it to penetrate the most advanced anti-access/area-denial systems. Gen. Kenneth Wilsbach, Chief of Staff of the U.S. Air Force, also said that fielding ARRW would enhance the ability to hold targets worldwide at risk.

However, the production phase and the operational deployment are different. Actual production, testing, missile delivery, integration with bombers, and preparation of operating units remain. The U.S. Air Force plans to initially integrate ARRW with the B-52 bomber, and has also been working on integration with the B-1 bomber.

A contract is not necessarily a deployment schedule.

The delivery date of the first production missiles and the actual deployment date of the bomber units have not been disclosed. The production quantity has also not been disclosed. Therefore, while this contract indicates that the project has moved into the production phase, it does not reveal how many missiles the U.S. military will operate or when.

Confirmed contracts, unconfirmed combat capabilities.

The FY2027 budget request includes $296 million for the development of the terminal seeker and datalink for ARRW Increment 2. The budget language for ARRW Increment 2 was included under the Pacific Deterrence Initiative. This can be viewed as a move by the United States to once again expand its long-range hypersonic strike options.

However, there is a difference between describing a weapon as capable of penetrating air defenses and demonstrating its performance against an actual enemy air defense and missile defense system. The claim that the ARRW can actually penetrate the air defense and missile defense systems of Russia or China has not been verified by publicly available operational data.

Past test records are also available. While the December 2022 test was a significant advancement, there were tests in 2023 that failed due to defects related to the cover and thermal shielding. These records do not preclude a production transition, but they leave open the debate surrounding the weapon’s reliability and maturity.

The term “hypersonic” does not substitute for actual verification.

It is also difficult to determine the actual scale of a project based solely on the contract amount. The quantity and unit price of the missiles included in the $694 million contract have not been disclosed. The U.S. Congress and taxpayers need to consider why the project is needed again after the 2023 suspension and what has changed.

The actual deployment is still undecided.

This contract confirms that the ARRW program has transitioned to the production phase. Lockheed Martin has received a production contract worth $694 million. For the subsequent Increment 2, a budget of $296 million is requested for development, testing, evaluation, and cost reduction activities.

By contrast, the production quantity, delivery schedule, and date of actual operational deployment have not been disclosed. Based solely on publicly available information, it is also impossible to determine whether this contract covers only the existing ARRW configuration or also upgraded variants related to Increment 2. Nor has it been confirmed whether ARRW will become the U.S. military’s first hypersonic weapon to enter operational service.

Therefore, the answer is clear at this time. While the ARRW has been revived through a production contract, its actual deployment by the U.S. military is not yet complete. Until the quantity and schedule are revealed, it is necessary to distinguish between the resumption of production and its operational deployment.

Production is the starting point; it is not the same as completion of deployment.

Frequently Asked Questions.

Does the ARRW production contract mean that it will soon be deployed for actual use?

No. While a production contract has been signed, the production quantity, the timing of missile delivery, and the actual deployment schedule for operational units have not been disclosed.

How many ARRW missiles did the U.S. Air Force order?

The exact production quantity has not been disclosed. Therefore, it is not possible to calculate the total number of missiles or the cost per missile based solely on the $694 million contract.

Why is the ARRW, which was planned to be discontinued in 2023, being produced again?

The U.S. Air Force announced that following the problems with the 2023 test, it would halt ARRW procurement and focus resources on HACM. Subsequently, beginning with the FY2026 budget, it included funding for ARRW procurement again and also pursued Increment 2 development in FY2027. This can be seen as an effort to maintain multiple hypersonic weapon options.

What is the difference between ARRW and HACM?

ARRW is a boost-glide system in which a rocket booster accelerates it before it glides. HACM is a scramjet-based, air-breathing hypersonic cruise missile.

Can the ARRW actually penetrate enemy air defense systems?

The U.S. Air Force describes the ARRW as a high-speed strike weapon capable of penetrating air defense systems. However, there is no publicly available information confirming its actual combat performance against Russian or Chinese air defense and missile defense systems.

DEFENSE DIGEST Editorial Team
Facebook X (Twitter) Copy link